Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Accumulated Expenses (2016 - 2025)

Adma Biologics (ADMA) has disclosed Other Accumulated Expenses for 8 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 108.82% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2025, up 108.82%, and an annual FY2025 reading of $4.2 million, up 108.82% over the prior year.
  • Other Accumulated Expenses was $4.2 million for Q4 2025 at Adma Biologics, up from $2.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $17.5 million in Q2 2025 and bottomed at $981721.0 in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $3.1 million, with a median of $2.3 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses crashed 33.89% in 2023, then surged 663.13% in 2025.
  • Year by year, Other Accumulated Expenses stood at $981721.0 in 2021, then surged by 82.94% to $1.8 million in 2022, then soared by 31.68% to $2.4 million in 2023, then fell by 15.6% to $2.0 million in 2024, then skyrocketed by 108.82% to $4.2 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for ADMA at $4.2 million in Q4 2025, $2.6 million in Q3 2025, and $17.5 million in Q2 2025.